New Treatments for Neuropathic Pain
Author Information
Author(s): Kontor Ernest Kissi, Wellan Catherine, Maaz Hafiz Mohammad, Muhammad Daha Garba, Al-Qiami Almonzer, Sharifan Amin, Kumah Jessica, Lacey Hester, Siddiq Abdelmonem, Jain Nityanand
Hypothesis
This meta-analysis aims to evaluate the efficacy and safety of novel drugs and devices targeting neuronal excitability in neuropathic pain patients compared to control interventions.
Conclusion
Device-based interventions are more effective than control interventions in reducing pain intensity in neuropathic pain, but evidence is limited due to heterogeneity and publication bias.
Supporting Evidence
- Device-based interventions were found to be more effective in reducing pain scores than control interventions.
- Drug interventions did not differ from placebo in absolute pain reduction but were effective in relative change from baseline.
- High heterogeneity was observed in the results, indicating variability in treatment effects.
- Publication bias was suggested by the asymmetry in the funnel plot.
Takeaway
This study found that new devices can help reduce pain for people with nerve pain, but more research is needed to confirm these results.
Methodology
The study reviewed 30 randomized controlled trials comparing novel devices and drugs for neuropathic pain against placebo or usual care.
Potential Biases
Publication bias was suggested by funnel plot asymmetry.
Limitations
The evidence is limited due to high heterogeneity among studies and potential publication bias.
Participant Demographics
Participants included adults aged 18 and older with various etiologies of neuropathic pain.
Statistical Information
P-Value
p < 0.01
Confidence Interval
95% CI: −1.92 to −0.62
Statistical Significance
p < 0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website